These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11855380)

  • 21. The role of telomeres and telomerase in cancer.
    Goldman MA
    Drug Discov Today; 2003 Apr; 8(7):294-6. PubMed ID: 12654541
    [No Abstract]   [Full Text] [Related]  

  • 22. Telomerase as a Cancer Target. Development of New Molecules.
    Gomez DL; Armando RG; Cerrudo CS; Ghiringhelli PD; Gomez DE
    Curr Top Med Chem; 2016; 16(22):2432-40. PubMed ID: 26873194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Telomeres, telomerase and cancer].
    Soria JC; Rixe O
    Bull Cancer; 1997 Oct; 84(10):963-70. PubMed ID: 9435798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New prospects for targeting telomerase beyond the telomere.
    Arndt GM; MacKenzie KL
    Nat Rev Cancer; 2016 Aug; 16(8):508-24. PubMed ID: 27339602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crossroads of telomere biology and anticancer drug discovery.
    Seimiya H
    Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting human telomerase by antisense oligonucleotides and ribozymes.
    Folini M; Pennati M; Zaffaroni N
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomerase: biology and phase I trials.
    Kelland LR
    Lancet Oncol; 2001 Feb; 2(2):95-102. PubMed ID: 11905801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural and pharmacological regulation of telomerase.
    Mergny JL; Riou JF; Mailliet P; Teulade-Fichou MP; Gilson E
    Nucleic Acids Res; 2002 Feb; 30(4):839-65. PubMed ID: 11842096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomeres and telomerases in cancer.
    Novak KD
    MedGenMed; 2003 Jan; 5(1):21. PubMed ID: 12827082
    [No Abstract]   [Full Text] [Related]  

  • 34. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Telomere-Related Pharmacological Targets.
    Berei J; Eckburg A; Miliavski E; Anderson AD; Miller RJ; Dein J; Giuffre AM; Tang D; Deb S; Racherla KS; Patel M; Vela MS; Puri N
    Curr Top Med Chem; 2020; 20(6):458-484. PubMed ID: 31916516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Telomeres and telomerase, new targets for anticancer chemotherapy].
    Riou JF; Morjani H; Trentesaux C
    Ann Pharm Fr; 2006 Mar; 64(2):97-105. PubMed ID: 16568010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase inhibitors in cancer therapy: current status and future directions.
    Incles CM; Schultes CM; Neidle S
    Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomere maintenance and cancer -- look, no telomerase.
    Neumann AA; Reddel RR
    Nat Rev Cancer; 2002 Nov; 2(11):879-84. PubMed ID: 12415258
    [No Abstract]   [Full Text] [Related]  

  • 39. [Physiopathologic implications of telomerase].
    Santos Ruiz A; Cascales Angosto M
    An R Acad Nac Med (Madr); 2000; 117(2):427-44; discussion 444-7. PubMed ID: 11209552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase, telomerase inhibition, and cancer.
    Ahmed A; Tollefsbol TO
    J Anti Aging Med; 2003; 6(4):315-25. PubMed ID: 15142433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.